- IN8bio will hold its 2026 annual meeting as a virtual meeting on May 7, 2026.
- Shareholders will vote on the election of two Class II director nominees, Peter Brandt and Corinne Epperly, to serve until the 2029 annual meeting.
- The meeting will also include a proposal to ratify CohnReznick as IN8bio’s independent registered public accounting firm.
- Another proposal seeks approval of an amended and restated 2026 equity incentive plan, including an increase of 2,920,000 shares available for issuance.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IN8BIO Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-126208), on March 26, 2026, and is solely responsible for the information contained therein.